Get the Stockscreener App
4.745
4.06%
-0.295
BiomX Inc stock is traded at $4.745, with a volume of 4,841.
It is down -4.06% in the last 24 hours and down -7.55% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$5.04
Open:
$4.89
24h Volume:
4,841
Relative Volume:
0.01
Market Cap:
$7.65M
Revenue:
-
Net Income/Loss:
$-36.20M
P/E Ratio:
-0.1987
EPS:
-23.8772
Net Cash Flow:
$-26.39M
1W Performance:
-24.09%
1M Performance:
-7.55%
6M Performance:
-52.52%
1Y Performance:
-58.16%
1-Day Range:
$4.80
$4.89
1-Week Range:
$4.67
$6.7502
52-Week Range:
$1.5004
$14.71
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
4.80 | 8.03M | 0 | -36.20M | -26.39M | -23.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.93 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
743.61 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
685.74 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.69 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.76 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomX CEO Issues Letter to Stockholders - marketscreener.com
BiomX (PHGE) director-linked LLC sells common shares and warrants - Stock Titan
Aug Technicals: Is BiomX Inc a cyclical or defensive stock2026 Update & High Accuracy Investment Signals - baoquankhu1.vn
Bidas Liat Cohavi Net Worth (2026) - GuruFocus
Stock Market Recap: Can BiomX Inc outperform in the next rallyJobs Report & Weekly Breakout Stock Alerts - baoquankhu1.vn
BiomX appoints Michael Oster CEO, David Rokach CFO - Investing.com Nigeria
BiomX (PHGE) 10% owner’s entity converts preferred and sells 670,000 shares - Stock Titan
Aug Selloffs: Is BiomX Inc gaining market shareEarnings Overview Summary & High Accuracy Trade Signal Alerts - baoquankhu1.vn
BiomX Shareholders Approve Expanded Common Stock Issuance Authorization - The Globe and Mail
Breakouts Watch: Why is BiomX Inc stock going up2026 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
PHGE SEC FilingsBiomx Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BiomX Inc. Files Form 8-K Current Report with SEC – Company Details, Stock Symbol PHGE, and NYSE American Listing - Minichart
Gap Down: Why is BiomX Inc stock going upMarket Risk Report & AI Forecasted Entry and Exit Points - baoquankhu1.vn
BiomX Inc. (PHGE) stockholders back all proposals at March 11, 2026 special meeting - Stock Titan
Biomx Inc. Appoints Alex Wong as Chief Information Technology Officerfor Hong Kong and Macau - marketscreener.com
BiomX appoints Michael Oster CEO, David Rokach CFO By Investing.com - Investing.com Canada
BiomX (PHGE) Appoints New CEO and CFO to Strengthen Leadership T - GuruFocus
BiomX names Michael Oster as CEO, David Rokach as CFO - TipRanks
BiomX downgraded to Neutral from Buy at H.C. Wainwright - TipRanks
PHGE: BiomX Downgraded to Neutral by HC Wainwright & Co. | PHGE Stock News - GuruFocus
H.C. Wainwright downgrades BiomX stock rating to neutral By Investing.com - Investing.com Australia
H.C. Wainwright downgrades BiomX stock rating to neutral - Investing.com
BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of Growth - marketscreener.com
BiomX Inc. Appoints Michael Oster as Chief Executive Officer - marketscreener.com
Sentiment Watch: Is BiomX Inc a strong candidate for buy and holdEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
Breakout Move: Can BiomX Inc outperform in the next rally2026 Major Catalysts & Fast Moving Trade Plans - baoquankhu1.vn
BiomX announces CEO and board changes, appoints Michael Oster as chief executive - Investing.com Australia
Can BiomX Inc. stock deliver strong Q4 earningsWeekly Market Summary & Daily Entry Point Trade Alerts - Naître et grandir
Aug Final Week: Can BiomX Inc maintain sales growthJuly 2025 Institutional & Breakout Confirmation Trade Signals - baoquankhu1.vn
BiomX (PHGE) taps Michael Oster as CEO as Solomon and chair exit - Stock Titan
Biomx IncJonathan Solomon resigns as CEO and board member effective March 4, 2026SEC filing - marketscreener.com
PHGE Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
[Form 3] BiomX Inc. Initial Statement of Beneficial Ownership - Stock Titan
BiomX Adjourns Special Shareholder Meeting for Lack of Quorum - The Globe and Mail
BiomX Inc. Announces Management Changes - marketscreener.com
Leadership shake-up at BiomX (PHGE) as executives quit and new CFO named - Stock Titan
Aug Wrap: Does BiomX Inc have a sustainable dividendJuly 2025 Volume & AI Driven Price Predictions - baoquankhu1.vn
PHGE Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
BiomX (PHGE) adds two independent board members after Alan Moses resigns - Stock Titan
PHGE Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BiomX: Meeting adjourned and rescheduled due to lack of quorum; voting instructions remain valid - TradingView
BiomX: Meeting adjourned for lack of quorum; rescheduled for March 11, 2026 - TradingView
Bull Bear: Does BiomX Inc outperform in volatile marketsJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
BiomX Inc. SEC 10-K Report - TradingView
MSN Money - MSN
Alyeska details 2.5% BiomX (PHGE) stake in amended 13G filing - Stock Titan
Does BiomX Inc. stock have upside surprise potentialJuly 2025 Drop Watch & Risk Managed Investment Signals - mfd.ru
BiomX Inc. Announces Board Changes - marketscreener.com
Is BiomX Inc. trading at a discountJuly 2025 Levels & Weekly Breakout Opportunity Watchlist - mfd.ru
PHGE Should I Buy - Intellectia AI
Deerfield’s 9.99% BiomX (PHGE) stake and board resignation detail - Stock Titan
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):